Ami Asset Management Has Raised Its Science Applications Intl (SAIC) Stake by $1.95 Million as Stock Value Declined; Equitec Specialists Holding in Teva Pharmaceutical Inds LTD (Call) (TEVA) Has Boosted as Share Price Declined

January 7, 2018 - By Marie Mckinney

Ami Asset Management Corp increased its stake in Science Applications Intl Corp (SAIC) by 21.32% based on its latest 2017Q3 regulatory filing with the SEC. Ami Asset Management Corp bought 29,566 shares as the company’s stock declined 17.93% while stock markets rallied. The hedge fund held 168,251 shares of the edp services company at the end of 2017Q3, valued at $11.25 million, up from 138,685 at the end of the previous reported quarter. Ami Asset Management Corp who had been investing in Science Applications Intl Corp for a number of months, seems to be bullish on the $3.34B market cap company. The stock increased 0.04% or $0.03 during the last trading session, reaching $77.99. About 164,581 shares traded. Science Applications International Corporation (NYSE:SAIC) has risen 37.99% since January 7, 2017 and is uptrending. It has outperformed by 21.29% the S&P500.

Equitec Specialists Llc increased its stake in Teva Pharmaceutical Inds Ltd (Call) (TEVA) by 110.71% based on its latest 2017Q3 regulatory filing with the SEC. Equitec Specialists Llc bought 18,600 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 35,400 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $623,000, up from 16,800 at the end of the previous reported quarter. Equitec Specialists Llc who had been investing in Teva Pharmaceutical Inds Ltd (Call) for a number of months, seems to be bullish on the $19.53B market cap company. The stock decreased 1.84% or $0.36 during the last trading session, reaching $19.22. About 13.27 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 7, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Since August 17, 2017, it had 0 buys, and 2 insider sales for $2.27 million activity.

Ami Asset Management Corp, which manages about $1.42 billion and $1.41B US Long portfolio, decreased its stake in Virtusa Corp Com (NASDAQ:VRTU) by 65,087 shares to 251,407 shares, valued at $9.50 million in 2017Q3, according to the filing. It also reduced its holding in Anika Therapeutics Inc Com (NASDAQ:ANIK) by 26,643 shares in the quarter, leaving it with 282,416 shares, and cut its stake in Healthcare Svcs Gp Inc Com (NASDAQ:HCSG).

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.08, from 0.93 in 2017Q2. It dropped, as 30 investors sold SAIC shares while 77 reduced holdings. 22 funds opened positions while 69 raised stakes. 26.26 million shares or 4.01% less from 27.36 million shares in 2017Q2 were reported. Axa stated it has 0% of its portfolio in Science Applications International Corporation (NYSE:SAIC). Franklin Resource Inc has invested 0% in Science Applications International Corporation (NYSE:SAIC). New York-based Mutual Of America Cap Lc has invested 0.11% in Science Applications International Corporation (NYSE:SAIC). The Washington-based Cornerstone Advsr Inc has invested 0% in Science Applications International Corporation (NYSE:SAIC). Price T Rowe Associates Md holds 0% or 21,694 shares in its portfolio. Century owns 46,609 shares. Cwm Ltd Liability Corp invested in 0% or 6 shares. Edge Wealth Mgmt Limited Company stated it has 0% of its portfolio in Science Applications International Corporation (NYSE:SAIC). Susquehanna Intll Group Llp invested in 17,202 shares or 0% of the stock. Arizona State Retirement Sys holds 0.02% or 24,761 shares in its portfolio. Aperio Gru Ltd Limited Liability Company reported 16,063 shares. Meeder Asset Mgmt holds 0% or 635 shares. Thrivent Fin For Lutherans has 9,558 shares. Dimensional Fund Advsrs Limited Partnership reported 0.03% stake. Oakbrook Invests Ltd Liability Corporation has 3,300 shares.

Among 10 analysts covering Science Applications International (NYSE:SAIC), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Science Applications International had 29 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Buy” rating by Citigroup on Wednesday, September 2. The stock of Science Applications International Corporation (NYSE:SAIC) earned “Buy” rating by Vertical Research on Friday, December 8. The firm has “Hold” rating given on Wednesday, September 20 by Jefferies. The firm earned “Buy” rating on Thursday, February 16 by Seaport Global Securities. The stock of Science Applications International Corporation (NYSE:SAIC) has “Hold” rating given on Thursday, December 7 by Jefferies. The firm has “Buy” rating given on Tuesday, June 14 by Citigroup. Jefferies downgraded Science Applications International Corporation (NYSE:SAIC) on Monday, July 17 to “Hold” rating. On Monday, June 13 the stock rating was downgraded by BB&T Capital to “Hold”. The firm has “Buy” rating given on Thursday, December 10 by Suntrust Robinson. As per Wednesday, June 15, the company rating was maintained by Jefferies.

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 7 Sell and 18 Hold. Therefore 24% are positive. Teva Pharma had 125 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Hold” rating by Maxim Group on Thursday, July 13. As per Monday, November 13, the company rating was maintained by Citigroup. Barclays Capital maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Monday, August 7. Barclays Capital has “Equal-Weight” rating and $23 target. As per Tuesday, January 31, the company rating was upgraded by Bank of America. The firm has “Hold” rating by Oppenheimer given on Wednesday, October 4. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Neutral” rating given on Friday, December 15 by Credit Suisse. The stock has “Buy” rating by RBC Capital Markets on Friday, June 16. Mizuho maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Thursday, August 25 with “Buy” rating. On Monday, August 10 the stock rating was maintained by Goldman Sachs with “Buy”. The firm has “Outperform” rating given on Wednesday, April 5 by Cowen & Co.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>